z-logo
open-access-imgOpen Access
Assessment of the Risk and the Prophylaxis of Venous Thromboembolism in Surgical Patients
Author(s) -
David Bergqvist
Publication year - 2003
Publication title -
pathophysiology of haemostasis and thrombosis
Language(s) - English
Resource type - Journals
eISSN - 1424-8840
pISSN - 1424-8832
DOI - 10.1159/000083829
Subject(s) - medicine , fondaparinux , venous thromboembolism , low molecular weight heparin , surgery , ximelagatran , heparin , anesthesia , warfarin , thrombosis , dabigatran , atrial fibrillation
This review article first deals with risk factors for developing postoperative venous thromboembolism. The various pharmacological prophylactic methods available today are summarized with focus on dominating method low molecular weight heparin and the two new ones, the Xa inhibitor fondaparinux and the IIa inhibitor ximelagatran, both approved in orthopaedic surgery. The optimal timing to start prophylaxis is between 2 hours before and 10 hours after surgery. Evidence is accumulating that some in risk groups prolonged prophylaxis is indicated, ie. elective hip surgery, probably hip fracture surgery and probably also patients operated on for abdominal/pelvic cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom